Home › Trial NCT05011045
Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies
- Trial IDNCT05011045
- StatusRecruiting
- PhaseN/A
- Study typeObservational
- SponsorM.D. Anderson Cancer Center
- Enrollment100
- Start date2020-01-09
- ConditionsCentral Nervous System Lymphoma · Hematopoietic and Lymphoid Cell Neoplasm · Leukemia · Lymphoma · Plasma Cell Myeloma · Secondary Central Nervous System Lymphoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.